NFXF Blog
Featured
The initiative will build on our 40 years of work, promoting broader use of evidence-based information among individuals with FXS, caregivers, family members, community partners, and healthcare providers nationwide.
Why Fragile X Syndrome Treatment Information Feels So Confusing
08 mins read
FXS Tips & Support for Traveling + Free Downloads
06 mins read
Advocacy is Year-Round: What That Looks Like
05 mins read
Understanding What the Texas v. Kennedy Ruling Means for Community Living
03 mins read
All Articles
Carme Torrents, MD, a 2026 Jr. Investigators Awardee, summarizes an important symposium by Drs. Elizabeth Smith, Tatyana Adayev, and Anne Wheeler, during the 20th International Fragile X Conference.
Tetsuya Asano, a 2026 Jr. Investigators Awardee, summarizes an important talk by Jessica Klusek during the 20th International Fragile X Conference.
Research Summary: This research was very revealing. Currently, we do not have accurate methods to predict who will develop FXTAS and who will not, or when the disease will start.
The neurodegenerative symptoms investigated in this study are due to FXTAS.


